SCHEMBL5899466

SCHEMBL5899466

CC(C)(NS(=O)(=O)Cc1ccccc1)C(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
MMP1 P03956 1/20 0.50
MMP2 P08253 1/20 0.50
MMP9 P14780 1/20 0.50
MMP8 P22894 1/20 0.50
MMP13 P45452 1/20 0.50
HPGD P15428 1/20 0.49
KMT2A Q03164 1/20 0.43
SLC1A3 P43003 1/20 0.42
SLC1A2 P43004 1/20 0.42
SLC1A1 P43005 1/20 0.42
HSD17B10 Q99714 2/20 0.42
ALOX15 P16050 1/20 0.42
FAAH O00519 1/20 0.42
PRSS1 P07477 1/20 0.42
PRSS2 P07478 1/20 0.42
ELANE P08246 1/20 0.42
PRTN3 P24158 1/20 0.42
PRSS3 P35030 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899426 0.90 ALDH1A1 (0.46) CA1CA2MMP1MMP2MMP9
SCHEMBL5899461 0.86 ACLY (0.47) HPGDKMT2AGAAMAPTSTS
SCHEMBL14675961 0.85 CA1 (0.55) CA1CA2MMP1MMP2MMP9
SCHEMBL5963267 0.85 CA1 (0.55) CA1CA2MMP1MMP2MMP9
SCHEMBL634086 0.78 CA1 (0.57) CA1CA2MMP1MMP2MMP9
SCHEMBL5899488 0.76 KAT6A (0.49) CA1CA2MMP1MMP2MMP9
SCHEMBL13543300 0.75 HPGD (0.72) CA1CA2MMP1MMP2MMP9
SCHEMBL5264576 0.74 CA1 (0.57) CA1CA2MMP1MMP2MMP9
SCHEMBL14676803 0.73 ACLY (0.47) KMT2APTPN1ALDH1A1
SCHEMBL6813980 0.73 KMT2A (0.44) CA1CA2MMP1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 CA1 1910/4885CA2 3489/4885MMP1 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.